- Home
- AXS vs CRL Comparison
AXS vs CRL Comparison
Compare AXS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXS | CRL |
|---|---|---|
| Founded | 2001 | 1947 |
| Country | Bermuda | United States |
| Employees | 1876 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.6B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | AXS | CRL |
|---|---|---|
| Price | $99.35 | $168.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $121.29 | ★ $198.27 |
| AVG Volume (30 Days) | 492.8K | ★ 695.3K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $2.53 | N/A |
| Revenue Next Year | $6.95 | $3.04 |
| P/E Ratio | $8.43 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $88.07 | $132.58 |
| 52 Week High | $110.34 | $228.88 |
Technical Indicators
Market Signals| Indicator | AXS | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 47.22 | 46.01 |
| Support Level | $98.13 | $161.39 |
| Resistance Level | $103.06 | $184.75 |
| Average True Range (ATR) | 2.42 | 8.33 |
| MACD | -0.04 | -0.39 |
| Stochastic Oscillator | 45.32 | 22.39 |
Price Performance
Historical ComparisonAbout AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.